EHC and EUPATI Partner to Advance Patient Education and Engagement in Therapeutic Innovation
The European Haemophilia Consortium (EHC) recently shared an announcement post on X:
”EHC has partnered with The European Patients’ Academy on Therapeutic Innovation to enhance education and research for European Patients. Together, we’ll strengthen the voice of the rare Bleeding Disorders community & improve outcomes across Europe.”
To read more, follow the link.
European Haemophilia Consortium has announced a new partnership with the European Patients’ Academy of Therapeutic Innovation (EUPATI), a nonprofit foundation dedicated to educating patients and the public on the medicine development process.
Representing over 120,000 individuals with rare bleeding disorders, the Consortium brings deep patient insight and multi-stakeholder collaboration to the alliance.
This partnership reflects both organizations’ shared commitment to empowering patients and strengthening the role of informed, engaged communities in shaping the future of healthcare.
Learn about the latest major collaborations in the field of Rare Diseases with Hemostasis Today.
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand
-
Aug 26, 2026, 13:54Giuseppe Biondi Zoccai: Congratulations to the Next Editor-in-Chief of the EHJ
-
Aug 26, 2026, 13:25Omar Adwan: Abnormal Nuclear Morphology of Neutrophil
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?